首页> 外文OA文献 >A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer

【2h】

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer

机译：纳米颗粒掺入的尖锐活化剂可增强三阴性乳腺癌的PD-L1不敏感模型中的抗肿瘤免疫力

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ning Cheng; Rebekah Watkins-Schulz; Robert D. Junkins; Clément N. David; Brandon M. Johnson; Stephanie A. Montgomery; Kevin J. Peine; David B. Darr; Hong Yuan; Karen P. McKinnon; Qi Liu; Lei Miao; Leaf Huang; Eric M. Bachelder; Kristy M. Ainslie; Jenny P-Y Ting;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors (vol 22, pg 1499, 2016) [J] . Loi Sherene, Dushyanthen Sathana, Beavis Paul A., Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第4期

机译：RAS / MAPK激活与三重阴性乳腺癌中的肿瘤浸润淋巴细胞减少相关：MEK和PD-1 / PD-L1免疫检查点抑制剂之间的治疗合作（Vol 22，PG 1499,2016）
2. RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors [J] . Loi Sherene, Dushyanthen Sathana, Beavis Paul A., Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第6期

机译：RAS / MAPK激活与三阴性乳腺癌中肿瘤浸润淋巴细胞减少有关：MEK和PD-1 / PD-L1免疫检查点抑制剂之间的治疗合作
3. PARP Inhibitor Efficacy Depends on CD8(+) T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer [J] . Pantelidou Constantia, Sonzogni Olmo, Taveira Mateus De Oliveria, Cancer discovery. . 2019,第6期

机译：PARP抑制剂功效取决于CD8（+）T细胞通过BRCA缺陷的三重阴性乳腺癌模型中的肿瘤型术语激活募集
4. Simulating an Immune Response with a Combined Agent-Based Model of a Triple-Negative Breast Cancer Tumor and Vascular Network [C] . Michael Ventoso, Kerri-Ann Norton IEEE International Conference on Bioinformatics and Biomedicine . 2020

机译：用三重阴性乳腺癌肿瘤和血管网络的基于组合药物的免疫应答模拟免疫应答
5. Membrane anchored immune stimulatory proteins enhance anti-tumor immunity in breast cancer models [D] . Bozeman, Erica N. 2013

机译：膜锚定的免疫刺激蛋白增强乳腺癌模型的抗肿瘤免疫力
6. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer [O] . Ning Cheng, Rebekah Watkins-Schulz, Robert D. Junkins, 2018

机译：掺入纳米粒子的STING激活剂增强PD-L1不敏感的三阴性乳腺癌模型中的抗肿瘤免疫力
7. Correction: RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors [O] . Sherene Loi, Sathana Dushyanthen, Paul A. Beavis, 2019

机译：校正：RAS / MAPK激活与三重阴性乳腺癌中的肿瘤浸润淋巴细胞减少相关：MEK和PD-1 / PD-L1免疫检查点抑制剂之间的治疗合作

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅